Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New registry tracks radiation side effects in metastatic cancer patients

NCT ID NCT04085029

First seen Feb 05, 2026 · Last updated Jun 15, 2026 · Updated 21 times

Summary

This study is a registry that collects information from 300 adults with cancer that has spread to other parts of the body. Participants receive or have received a special type of high-dose radiation called ablative radiotherapy. The goal is to track and understand the short-term side effects of this treatment to help doctors improve care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke Cancer Institute Cary

    RECRUITING

    Cary, North Carolina, 27518, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Duke Raleigh Hospital

    RECRUITING

    Raleigh, North Carolina, 27609, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Duke Women's Cancer Care Raleigh

    RECRUITING

    Raleigh, North Carolina, 27607, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Durham Veterans Administration Health Care System (DVAHCS)

    RECRUITING

    Durham, North Carolina, 27705, United States

    Contact

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.